Source: https://www.fortunebusinessinsights.com/electroencephalography-devices-market-114798
The global electroencephalography (EEG) devices market is on a robust growth trajectory. According to Fortune Business Insights, the market is projected to grow from USD 1.64 billion in 2026 to USD 3.17 billion by 2034, exhibiting a compound annual growth rate (CAGR) of 8.4% during the forecast period. The study period spans 2021–2034, with 2025 as the base year.
EEG devices measure and record electrical activity in the brain, making them essential diagnostic tools for detecting and monitoring neurological conditions such as epilepsy, Alzheimer's disease, sleep disorders, and brain tumors.
Technological Advancements: Significant progress in EEG technology is enabling more precise and efficient diagnosis of neurological disorders. Innovations such as combined high-definition transcranial electrical stimulation and EEG systems — like the MxN-GO EEG launched by Soterix Medical Inc. in April 2024 — are expanding clinical and research applications.
Rising Neurological Disorder Prevalence: The increasing burden of conditions like epilepsy, Alzheimer's, and sleep disorders is pushing demand for reliable, non-invasive brain monitoring. An aging global population, especially in North America where the population aged 65+ is projected to rise from 58 million in 2022 to 82 million by 2050, is accelerating this trend.
Expanding Healthcare Infrastructure: New neuroscience centers and dedicated neurology departments — such as KEM Hospital's Comprehensive Department of Neurosciences launched in June 2025 — are driving demand for advanced EEG diagnostic solutions.
By End Use: Hospitals and clinics held the largest market share in 2024, driven by the growing number of specialized neurology hospitals and the need for effective brain activity monitoring solutions. Diagnostic centers are projected to register the fastest growth over the forecast period.
By Product: The 40-channel EEG segment dominated market revenue in 2024, while wearable and portable EEG solutions are gaining significant traction due to their convenience and expanding use cases.
By Type: Standalone systems commanded the dominant share, valued for their high accuracy and comprehensive diagnostic capabilities. However, wearable EEG devices are expected to register the fastest CAGR going forward as remote and home-based monitoring gains acceptance.
North America held the largest share of the global EEG devices market in 2024. This dominance is supported by high healthcare expenditure, advanced medical infrastructure, robust R&D in neuroscience, and favorable reimbursement policies. In the U.S., Medicare covers ambulatory EEG under CPT codes 95812, 95813, 95816, 95819, and 95822, directly supporting adoption.
Asia Pacific is expected to grow at the highest CAGR during the forecast period, driven by rising healthcare investments, a large patient pool with neurological conditions, and increasing awareness of neurological health across the region.
The EEG devices market is fragmented, with no single player holding a dominant position. Key players identified by Fortune Business Insights include:
Companies are actively pursuing product innovation, regulatory approvals, and geographic expansion to strengthen their market positions. For instance, Samsung announced the development of ear-based EEG devices in October 2025, enabling real-time brain activity monitoring.
The global EEG devices market is positioned for consistent growth through 2034, underpinned by rising neurological disease burdens, technological innovation, and expanding clinical applications. Both standalone and wearable EEG solutions will play critical roles in shaping the market's future, with North America leading and Asia Pacific emerging as the fastest-growing region.
Report ID: FBI114798 | Last Updated: April 16, 2026 | Pages: 180 | Format: PDF Source: Fortune Business Insights – fortunebusinessinsights.com